Clinical trial
Detection of Borrelia Bacteria in Early Stage Lyme Borreliosis Using the T2Lyme Panel
NCT03581279 is registered in ClinicalTrials.gov with T2 Biosystems as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Detection of Borrelia Bacteria in Early Stage Lyme Borreliosis Using the T2Lyme Panel
- Lead sponsor
- T2 Biosystems
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- May 8, 2018
- Completion date
- October 31, 2019
- Enrollment
- 18 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.